Engineers Gate Manager LP Acadia Pharmaceuticals Inc Transaction History

Engineers Gate Manager LP

$5.42 Billion
Q4 2024

A detailed history of Engineers Gate Manager LP transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Engineers Gate Manager LP holds 99,948 shares of ACAD stock, worth $1.71 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

99,948

Previous 133,194 24.96%

Holding current value

$1.71 Million

Previous $2.05 Million 10.49%

% of portfolio

0.03%

Previous 0.04%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$14.29 - $18.76 $475,085 - $623,694	-33,246 Reduced 24.96%	99,948 $1.83 Million
Q3 2024 Nov 14, 2024	BUY	$15.14 - $19.14 $385,297 - $487,093	25,449 Added 23.62%	133,194 $2.05 Million
Q2 2024 Aug 14, 2024	SELL	$14.62 - $18.42 $1.42 Million - $1.79 Million	-96,928 Reduced 47.36%	107,745 $1.75 Million
Q1 2024 May 15, 2024	BUY	$17.79 - $30.86 $3.64 Million - $6.32 Million	204,673 New	204,673 $3.78 Million
Q3 2023 Nov 14, 2023	BUY	$20.84 - $33.47 $1.6 Million - $2.57 Million	76,880 Added 117.62%	142,241 $2.96 Million
Q2 2023 Aug 14, 2023	SELL	$17.8 - $25.65 $200,232 - $288,536	-11,249 Reduced 14.68%	65,361 $1.57 Million
Q1 2023 May 15, 2023	BUY	$16.32 - $20.92 $938,889 - $1.2 Million	57,530 Added 301.52%	76,610 $1.44 Million
Q4 2022 Feb 14, 2023	SELL	$14.2 - $18.63 $229,685 - $301,340	-16,175 Reduced 45.88%	19,080 $303,000
Q3 2022 Nov 14, 2022	BUY	$14.11 - $18.27 $36,234 - $46,917	2,568 Added 7.86%	35,255 $577,000
Q2 2022 Aug 15, 2022	BUY	$13.01 - $27.22 $425,257 - $889,740	32,687 New	32,687 $461,000
Q1 2022 May 16, 2022	SELL	$20.94 - $27.5 $509,239 - $668,772	-24,319 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$16.79 - $27.09 $408,316 - $658,801	24,319 New	24,319 $568,000
Q3 2021 Nov 15, 2021	SELL	$15.78 - $24.77 $174,053 - $273,213	-11,030 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$19.4 - $27.42 $578,993 - $818,349	-29,845 Reduced 73.02%	11,030 $269,000
Q1 2021 May 17, 2021	BUY	$25.02 - $54.99 $811,273 - $1.78 Million	32,425 Added 383.73%	40,875 $1.06 Million
Q4 2020 Feb 16, 2021	SELL	$41.04 - $56.79 $1.72 Million - $2.37 Million	-41,790 Reduced 83.18%	8,450 $452,000
Q3 2020 Nov 16, 2020	BUY	$36.42 - $57.0 $1.23 Million - $1.92 Million	33,688 Added 203.53%	50,240 $2.07 Million
Q2 2020 Aug 17, 2020	BUY	$39.26 - $52.73 $649,831 - $872,786	16,552 New	16,552 $802,000
Q1 2020 May 15, 2020	SELL	$31.65 - $46.87 $574,479 - $850,737	-18,151 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$36.21 - $51.4 $657,247 - $932,961	18,151 New	18,151 $776,000
Q3 2019 Nov 14, 2019	SELL	$22.22 - $44.01 $501,061 - $992,425	-22,550 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$23.32 - $28.12 $525,866 - $634,106	22,550 New	22,550 $603,000

Others Institutions Holding ACAD

# of Institutions

315

Shares Held

164M

Call Options Held

855K

Put Options Held

350K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.76B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Account

Engineers Gate Manager LP Acadia Pharmaceuticals Inc Transaction History